High-resolution melting analysis of the spa locus reveals significant diversity within sequence type 93 methicillin-resistant Staphylococcus aureus from northern Australia  by Tong, S.Y.C. et al.
High-resolution melting analysis of the spa locus reveals signiﬁcant
diversity within sequence type 93 methicillin-resistant Staphylococcus
aureus from northern Australia
S. Y. C. Tong, R. A. Lilliebridge, D. C. Holt, M. I. McDonald, B. J. Currie and P. M. Giffard
Menzies School of Health Research, Institute of Advanced Studies, Charles Darwin University, Darwin, NT, Australia
Abstract
High-resolution melting analysis is an inherently robust, easy and inexpensive approach to the examination of genomic regions contain-
ing single-nucleotide polymorphisms and hypervariable loci. Staphylococcus aureus sequence type (ST) 93 is a singleton, Panton–Valentine
leukocidin-positive clone unique to Australia. A high-resolution melting-based method for the identiﬁcation of ST93 was developed, and
a similar approach was used to reveal diversity within the spa locus of this lineage. Statistical and graphical methods that account for
instrumental and operator-dependent variation in high-resolution melting curves were developed, to allow greater conﬁdence and
reproducibility in deciding whether another curve is truly different from the baseline curve of an amplicon with known sequence. The
data support a very early acquisition, or multiple independent acquisitions, of SCCmec by ST93 methicillin-susceptible S. aureus (MSSA),
and the coexistence of MSSA and methicillin-resistant S. aureus versions of the same lineage within northern Australia.
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Introduction
In the evolving Australian epidemics of community-associated
methicillin-resistant Staphylococcus aureus (CA-MRSA), the
most common multilocus sequence types (MLSTs) are 1, 93
and 30 [1]. Sequence type (ST) 93 methicillin-resistant
S. aureus (MRSA), ﬁrst described in 2000 [2], is an MLST sin-
gleton clone, is typically Panton–Valentine leukocidin (PVL)-
positive, and is a major cause of severe CA-MRSA disease in
Australia [2–4]. The other common PVL-positive clone,
ST30-MRSA, probably arrived in Australia via large popula-
tion migrations in the 1980s [5]. ST93-MRSA is the most
rapidly expanding CA-MRSA clone throughout Australia [1],
and now constitutes 33% of Australian CA-MRSA isolates
(13th International Symposium on Staphylococci and Staphy-
lococcal Infections (ISSI, 2008), Abstract 110), and has also
been exported to the UK by travellers (13th ISSI, 2008,
Abstract 604). Previous investigators found little genetic
diversity within ST93-MRSA, suggesting that it arose from
one PVL-positive subtype of ST93 methicillin-susceptible
S. aureus (MSSA) [6].
The polymorphic X region of the staphylococcal protein A
(spa) gene rapidly evolves, and spa sequence typing can eluci-
date patterns of diversity within sequence types. High-resolu-
tion melting (HRM) analysis, a new approach to analysing
genetic variation, is cost-effective, simple, and robust. It has
been shown to be highly effective for resolving spa types [7].
Although empirical methods to deﬁne HRM curves as the
same or different have been used, such methods have not
been based upon statistical analysis [7].
Our aims were to: (i) develop an HRM-based method for
the rapid identiﬁcation of ST93; and (ii) determine the spa
locus diversity of ST93-MRSA, ST93-MSSA and ST30-MRSA
isolates from northern Australia. Of particular interest was
whether ST93-MRSA represents a highly conserved clone
with a very recent origin as compared with ST93-MSSA.
Materials and Methods
Isolates were collected in community-based studies of impe-
tigo conducted in remote Aboriginal communities from 2003
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to 2005 [8], and in a prospective study of CA-MRSA infec-
tions at the Royal Darwin Hospital (RDH) from 2006
to 2007 (47th ICAAC, 2007, Abstract L1141); three ST93-
MSSA isolates were collected in 1991 at the RDH (Table 1).
The community studies had revealed the highly divergent
clonal complex (CC) 75 to be the predominant S. aureus
clone in remote communities in northern Australia [8].
A robust and efﬁcient method for identifying ST93 was
developed. An ST93-speciﬁc single-nucleotide polymorphism
(SNP), glpF 165, was identiﬁed in the S. aureus MLST data-
base using the software Minimum SNPs [9]. This is a three-
state SNP, with the ‘C’ allele completely speciﬁc for ST93,
the ‘A’ allele completely speciﬁc for CC75, and the ‘T’ allele
possessed by all other known STs. To add redundancy, we
also used the MLST database-derived SNP aroE 252, which
has been determined to be diagnostic for ST93. This SNP
also has three allelic states [10], with the ‘G’ allele being
unique to ST93. Primers were designed to generate ampli-
cons containing these SNPs.
The diversity of ST93 was assessed by performing HRM
analysis of the spa locus of 30 isolates each, identiﬁed as
ST93-MRSA and ST93-MSSA. Additionally, 30 isolates of
PVL-positive ST30-MRSA from northern Australia, previously
characterized using a kinetic PCR method to examine eight
SNPs [10], were similarly analysed.
We used a Rotor-Gene 6000 instrument (Corbett Life
Science) for the HRM analysis. DNA was extracted using the
QIAamp DNA minikit protocol for Gram-positive bacteria
with lysostaphin. Each reaction contained 5 lL of Platinum
SYBR Green qPCRSuperMix-UDG (2x; Invitrogen Life Tech-
nologies), 0.5 lM each primer and 1 lL of a 1 : 5 dilution of
the DNA template in a ﬁnal volume of 10 lL. The real-time
PCR thermocycling parameters were: 50C for 2 min; 95C
for 2 min; 40 cycles of 95C for 5 s and 60C for 30 s; 72C
for 2 min; and 50C for 20 s; this was followed by HRM
ramping with ﬂuorescence data acquisition at 0.05C incre-
ments. The primers and HRM ramping temperatures are
shown in Table 2. Reactions were routinely carried out in
duplicate. The exported HRM curves are available as
Supporting Information. The spa locus was sequenced in
representative isolates that yielded the different curves, and
spa types were assigned according to the spa database [11].
We deﬁned 95% CIs for the HRM curves corresponding to
isolates of the same sequenced spa type by exporting the nor-
malized ﬂuorescence data of the HRM curves to calculate the
mean and standard deviation (SD) at each temperature of the
melting protocol. This was only performed when there were
at least six isolates of the same spa type. At each tempera-
ture, the 95% CIs were calculated as the mean ± (1.96 · SD).
We generated difference graphs by subtracting this mean
normalized ﬂuorescence from the normalized ﬂuorescence of
each curve at each temperature, and deﬁned the 95% CIs for
the difference graph as 0 ± (1.96 · SD).
Results
We developed HRM-based methods for the examination of
both SNP regions, SNP glpF 165 and SNP aroE 252, using
TABLE 1. High-resolution melting (HRM) curves and corresponding spa types and repeats
HRM curve (no. of isolates) spa genotype (no. sequenced) spa repeats
ST93-MRSAa
(Fig. 1c)
HRM curve 1 (23) t202 (8) 11-17-23-17-17-16-16-25
HRM curve 3 (2) t1819 (2) 11-17-23-17-16-16-25
HRM curve 4 (1) t4675 (1) 11-17-17-17-16-16-25
HRM curve 5 (4) t1811 (4) 11-17-17-16-16-25
ST93-MSSA
(Fig. 1d)
HRM curve 1 (26)a,b t202 (5) 11-17-23-17-17-16-16-25
HRM curve 2 (1)c t4178 (1) 11-17-23-17-17-16-16-16-25
HRM curve 6 (2)c t4699 (2) 11-17-16-16-25
HRM curve 10 (1)b t4698 (1) 04-16-16-25
ST30-MRSAa
(Fig. 1e)
HRM curve 7 (27) t019 (7) 08-16-02-16-02-25-17-24
HRM curve 8 (2) t138 (2) 08-16-02-25-17-24
HRM curve 9 (1) t4700 (1) 08-275-02-16-02-25-17-24
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus; ST, sequence type.
aAll ST93-MRSA, ST30-MRSA and 21 ST93-MSSA isolates were from the 2006–2007 Royal Darwin Hospital collection.
bSix ST93-MSSA isolates were from the 2003–2005 community-based studies.
cThree ST93-MSSA isolates were from the 1991 Royal Darwin Hospital collection.
TABLE 2. Primers and ramping temperatures for high-
resolution melting reactions
Primer
name Primer sequence (5¢–3¢)
Ramping
temperatures
(C)
glpF 165F ACCCAGCGGTGTCTTTAGCTCTTGCAT 72–84
glpF 165R ATACAATCGTTGCTCCGACA
aroE 252F GTGGATAGGGTATAATACAG 68–81
aroE252R ACCTGCGCCCAAAATTAAAA
spa1095F AGACGATCCTTCGGTGAGC 75–87
spa1517R GCTTTTGCAATGTCATTTACTG
CMI Tong et al. HRM spa analysis shows diversity within ST93-MRSA 1127
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 1126–1131
isolates of known ST. For each SNP region, three easily dis-
criminated curves were obtained (Fig. 1a,b). During the
development of the glpF 165 assay, some unexpected results
were obtained. The initial primer set allowed ampliﬁcation of
a product that generated identical HRM curves for ST93 and
CC75, even though CC75 is highly divergent from all other
S. aureus, and the two PCR products differed at seven
positions. Examination of the seven SNPs indicated a neutral
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FIG. 1. High-resolution melting curves of the glpF 165, aroE 252 and spa loci (c–f). (a) Representative curves corresponding to each allele at
glpF 165: C (black) is speciﬁc for ST93, and A (green) is speciﬁc for CC75. (b) Representative curves for the aroE 252 region: the black curve is
speciﬁc for sequence type (ST 93. (c) ST93 methicillin-resistant Staphylococcus aureus (ST93-MRSA) showing four curves: curve 1 (black), curve 3
(red), curve 4 (green), and curve 5 (yellow). (d) ST93 methicillin-susceptible S. aureus (ST93-MSSA) showing four curves: curve 1 (black), curve 2
(green), curve 6 (red), and curve 10 (yellow). (e) ST30-MRSA showing three curves: curve 7 (blue), curve 8 (red), and curve 9 (green). (f) ST93-
MRSA (black), ST93-MSSA (green) and ST30-MRSA (blue) combined.
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balance of hydrogen bonds, with an identical GC content.
Redesign of the primers (glpF 165F and glpF 165R) allowed
clear discrimination of ST93 and CC75, with the ampliﬁed
regions now having differing GC contents. Of the possible
ampliﬁed aroE 252 regions, ST93, among all the STs, has a
unique GC content as well as the highest melting tempera-
ture, and therefore generates a unique HRM curve. We
were unable to consistently generate an aroE amplicon for
CC75, and further work to better characterize this locus for
CC75 is proceeding. It was concluded that examining the
glpF 165 and aroE 252 SNP regions by HRM analysis is a
rapid and robust method for identifying ST93. It has the
added beneﬁts of incorporating redundancy and allowing the
identiﬁcation of CC75, which is another major northern
Australian clonal complex.
HRM analysis of the spa locus revealed four and three
clearly distinct curves for ST93-MRSA and ST93-MSSA iso-
lates, respectively (Fig. 1c,d and Table 1). Of 14 sequenced
ST93 isolates associated with HRM curve 1, 13 had the same
spa type of t202, and one contained an additional 24-bp
repeat, t4178. Closer examination of the t4178 HRM differ-
ence curve, with the mean t202 curve as the baseline,
revealed part of the curve sitting outside the 95% CI curve,
suggesting that the t4178 and t202 HRM curves are indeed
different (Fig. 2a). The ﬁve other curves correlated with dif-
ferent spa types. Comparison of the raw data of HRM curves
of two ST93-t202 isolates produced in another laboratory
[7] showed that they were consistent with our t202 curves,
although a part of the curve at 72C, well away from the
melting temperature, was outside the 95% CI (Fig. 2a).
Within ST30-MRSA, three slightly different curves could be
distinguished on both the normalized ﬂuorescence and the
difference curves (Figs 1e and 2b). The spa loci of seven iso-
lates with HRM curve 8 were sequenced; all had the same
spa type of t019. The two other curves correlated with dif-
ferent spa types (Table 1). Fig. 1f shows curves from all
three groups of isolates.
Discussion
All of the ST93-MRSA isolates were from the 2006–2007
hospital-based study, and the ﬁnding of four spa types within
these 30 isolates revealed surprising spa type diversity for a
group of chronologically and geographically localized isolates
from a hospital serving a population of only 176 000.
Similarly localized [12–14], and some even larger [15,16],
studies of CA-MRSA revealed no spa type diversity among
ST30, ST80 and USA300 isolates. The diversity in ST93-
MRSA more closely mirrors that seen in studies across
broader geographical regions and time periods, where single
STs contained up to ﬁve spa types [17–20]. Larsen et al.
[19,20] linked this diversity within ST80 and USA300 to mul-
tiple international importations of these strains into Den-
mark. Such importation could explain the diversity that we
demonstrated in the widely distributed ST30-MRSA, but not
that in ST93-MRSA.
The diversity in both ST93-MRSA and ST93-MSSA does
not support the hypothesis that ST93-MRSA is undergoing
an explosive clonal expansion derived from a recent single
instance of SCCmec acquisition. Rather, the data support an
early acquisition of SCCmec, with subsequent rearrange-
ments of the spa sequence or multiple independent acquisi-
tions of SCCmec, and coexistence of MSSA and MRSA
versions of the same lineage. A recent study of ST5 revealed
(a)
(b)
FIG. 2. Difference graph of high-resolution melting curves of spa
loci. (a) Curves for sequence type (ST) 93 isolates. The mean of the
known t202 curves was used as the baseline. The green lines indi-
cate the 95% CIs for the 13 t202 curves, and the thin black lines
indicate each t202 curve. The blue lines (AS t202) refer to t202
curves derived from the raw data of the study by Stephens et al. [7],
and sit within the 95% CI, whereas part of the t4178 (red) curve sits
outside the 95% CI. (b) Curves for ST30 isolates. The mean of the
known t019 curves was used as the baseline. The green lines indi-
cate the 95% CIs for the seven t019 curves, and the thin black lines
indicate each t019 curve.
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that SCCmec has probably been acquired repeatedly in
geographical regions within ST5, and predicted that MRSA
haplotypes within a geographical region should also be pres-
ent in MSSA from that region [21]. Our ﬁndings support this
prediction; for instance, the commonest spa type, t202, is
present in ST93-MRSA from RDH and in ST93-MSSA from
both RDH and community study collections. Interestingly, all
21 ST93-MSSA isolates from the 2006–2007 hospital collec-
tion were spa type t202, raising the possibility of a current
epidemic of ST93-MSSA-t202, as compared with endemic
ST93-MRSA. However, these 21 isolates were not linked epi-
demiologically in terms of time or patient residence, and only
one was nosocomially acquired.
HRM analysis is a single-step closed-tube reaction. It is
inherently robust, easy, and inexpensive to optimize and
perform. It can also be used to examine hypervariable loci
[7]. The derivation of SNP sets from sequence alignments
using the software Minimum SNPs, and the development of
HRM-based assays for the examination of these SNPs, is a
straightforward and efﬁcient approach for assembling geno-
typing procedures for speciﬁc purposes. We have been able
to accurately discriminate two major clones in northern
Australia from all other clones and also from each other.
HRM-mediated spa examination can differentiate closely
related spa types, and provides further resolving power for
genotyping. It is less expensive than full spa sequencing; each
sequencing reaction in our institution costs US $20, as com-
pared with US $0.50 for reagents for each HRM run. The
Rotor-Gene 6000 software and previous publications have
used a single HRM curve of an amplicon of known sequence as
the baseline to generate difference curves. However, despite
the robust methods, there is inevitably instrumental and oper-
ator error, resulting in slight variations in HRM curves gener-
ated from identical amplicons. We have developed a simple
technique that incorporates this variation and allows greater
conﬁdence and reproducibility in deciding whether another
curve is truly different from the baseline curve of known
sequence. With appropriate calibration of instruments, it
should also allow portability of the HRM curves and interlabo-
ratory comparison, as demonstrated in this article.
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